Literature DB >> 15661395

Abnormal erythroid differentiation in neonatal bcl-6-deficient mice.

Sadaki Asari1, Akemi Sakamoto, Seiji Okada, Yusuke Ohkubo, Masafumi Arima, Masahiko Hatano, Yoshikazu Kuroda, Takeshi Tokuhisa.   

Abstract

OBJECTIVE: The bcl-6 proto-oncogene is ubiquitously expressed in various tissues. Since we found out the smaller number of TER119(+) cells in the spleen of neonatal bcl-6-deficient (bcl-6(-/-)) mice compared with that of control (bcl-6(+/+)) littermates, we studied functions of bcl-6 in differentiation of erythroid lineage cells.
MATERIALS AND METHODS: Erythroblasts in the definitive erythropoiesis were separated into four subsets using anti-TER119 and anti-CD71 mAbs. The cell number and property of these four subsets in spleens of neonatal bcl-6(+/+) and bcl-6(-/-) mice were examined using a flow cytometry.
RESULTS: bcl-6 mRNA expression was detected in the TER119(high)CD71(high) subset, which is morphologically equivalent to basophilic erythroblasts, by reverse-transcribed polymerase chain reaction. High percentages of cells in the TER119(low)CD71(high) and TER119(high)CD71(high) subsets were in the cell cycle. The cell number of the TER119(high)CD71(high) subset in the spleen and the percentage of reticulocytes in the peripheral blood of neonatal bcl-6(-/-) mice were significantly lower than those of neonatal bcl-6(+/+) mice. However, the percentage of apoptotic cells and that of cells in the cell cycle in the TER119(high)CD71(high) subset of bcl-6(-/-) mice were similar to those of bcl-6(+/+) mice.
CONCLUSION: bcl-6 detected in the TER119(high)CD71(high) subset of erythroblasts in the spleen of neonatal mice may be required to retain the erythroblasts in the cell proliferation stage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661395     DOI: 10.1016/j.exphem.2004.10.001

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  10 in total

1.  ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.

Authors:  Nicolas Goardon; Julie A Lambert; Patrick Rodriguez; Philippe Nissaire; Sabine Herblot; Pierre Thibault; Dominique Dumenil; John Strouboulis; Paul-Henri Romeo; Trang Hoang
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

2.  Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2.

Authors:  Wolfgang Bauer; Martina Rauner; Michael Haase; Satu Kujawski; Laleh S Arabanian; Ivonne Habermann; Lorenz C Hofbauer; Gerhard Ehninger; Alexander Kiani
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

3.  Stage-specific differential DNA methylation data analysis during human erythropoiesis in chromosome 16.

Authors:  Najyah A Garoot; Byung Guk Kim
Journal:  Genet Res (Camb)       Date:  2018-07-17       Impact factor: 1.588

4.  FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis.

Authors:  Lindsay M Coe; Sangeetha Vadakke Madathil; Carla Casu; Beate Lanske; Stefano Rivella; Despina Sitara
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

5.  Notch1 regulates progenitor cell proliferation and differentiation during mouse yolk sac hematopoiesis.

Authors:  I Cortegano; P Melgar-Rojas; L Luna-Zurita; M Siguero-Álvarez; M A R Marcos; M L Gaspar; J L de la Pompa
Journal:  Cell Death Differ       Date:  2014-02-28       Impact factor: 15.828

6.  PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.

Authors:  Natalia A Kokorina; Celine J Granier; Stanislav O Zakharkin; Stephani Davis; Arnold B Rabson; Hatem E Sabaawy
Journal:  Exp Hematol       Date:  2012-08-22       Impact factor: 3.084

7.  Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia.

Authors:  Rafiou Agoro; Anna Montagna; Regina Goetz; Onyedikachi Aligbe; Gurinder Singh; Lindsay M Coe; Moosa Mohammadi; Stefano Rivella; Despina Sitara
Journal:  FASEB J       Date:  2018-02-26       Impact factor: 5.191

8.  Aberrant regulation of hematopoiesis by T cells in BAZF-deficient mice.

Authors:  Hal E Broxmeyer; Sarita Sehra; Scott Cooper; Lisa M Toney; Saritha Kusam; Jim J Aloor; Christophe C Marchal; Mary C Dinauer; Alexander L Dent
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

9.  EPO modulation of cell-cycle regulatory genes, and cell division, in primary bone marrow erythroblasts.

Authors:  Jing Fang; Madhu Menon; William Kapelle; Olga Bogacheva; Oleg Bogachev; Estelle Houde; Sarah Browne; Pradeep Sathyanarayana; Don M Wojchowski
Journal:  Blood       Date:  2007-06-04       Impact factor: 22.113

10.  Role of the transcriptional corepressor Bcor in embryonic stem cell differentiation and early embryonic development.

Authors:  Joseph Alan Wamstad; Connie Marie Corcoran; Anne Marjorie Keating; Vivian J Bardwell
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.